TP53 and cancer: DET and IDET limit the growth of cancer cells at different phases of the cell cycle in different cancer cell lines by downregulating CDK1, 2, 4, 6, cyclin A, B, D E, cdc2, and cdc25, and by upregulating p21, p27, and p53, leading to apoptosis.